
Director, National Health Innovation Centre (NHIC)
PAULINE ERICA TAY
Dr. Pauline Erica Tay is a distinguished figure in the biomedical and healthcare innovation sectors, currently serving as the Director of the National Health Innovation Centre (NHIC) in Singapore. In this capacity, she facilitates the development and commercialization of clinical innovations across public hospital groups, bridging the gap between scientific research and practical healthcare applications. Dr. Tay's academic journey includes a Ph.D. in Stem Cell Biology and a B.Sc. in Microbiology and Biochemistry from the National University of Singapore, complemented by a postgraduate certificate in Advanced Biotechnology from Osaka University School of Medicine in Japan. Her professional trajectory encompasses significant roles in both public and private sectors. She spent 12 years at the Agency for Science, Technology and Research (ASTAR), contributing to the development of Singapore's biomedical science sector. Her tenure at ASTAR involved establishing and managing research institutes and talent development programs, as well as participating in the formation of the Genetic Modification Advisory Committee and the Bioethics Advisory Committee. In the private sector, Dr. Tay has held positions such as Executive Director and Head of Innovation Partnerships at UBS, and Chief Operating Officer and Chief Scientific Officer at Celligenics, a stem cell technology startup. Dr. Tay is a sought-after speaker at international conferences and forums, sharing her expertise on healthcare innovation, technology commercialization, and the integration of scientific research into clinical practice. She has been featured in events such as the Centre for Healthcare Innovation's symposium, where she discussed advancements in clinical research and innovation. Her extensive experience and leadership in both scientific research and healthcare innovation make Dr. Pauline Erica Tay a highly respected voice in the biomedical community, dedicated to advancing healthcare solutions through strategic partnerships and technological advancements.